Yahoo Finance12d
Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
November 14, 2024--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will present data at ...
How to know if you’re a binge drinker
On my last trip to my local garden centre I saw several framed signs that were designed for garden bars or kitchen walls: ...
E!13d
Francesca Farago Details Health Complications That Led to Emergency C-Section of Twins
Francesca Farago and Jesse Sullivan welcomed a twin boy and girl on Nov. 11, and detailed the painful experience and ...
The Week10d
Kerala hospital conducts rare surgery, remove 9cm tumour from the liver of infant
KIMSHealth hospital, Thiruvananthapuram conducts 12-hour surgery to remove hepatoblastoma, a rare cancer from infant's liver ...
NOLA.com2d
Ochsner Children’s Hospital celebrates national recognition in three specialties earning the top ranking in Louisiana for the fourth straight year
For the fourth year in a row and since the inception of this level of recognition, Ochsner Children’s Hospital is the number ...
Le Lézard13d
Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024
"This presentation highlights the potential of our TAEUS technology to obtain liver fat fraction measurements in patients ... fact are "forward-looking statements" within the meaning of Section 27A of ...
Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD - The Liver Meeting® 2024
Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patientsBoth artificial ...